Tailored doses of cytostatic improve survival rate after stem cell transplantation

By tailoring doses of the cytostatics administered before the transplantation, the researchers achieved a higher rate of survival with minimal adverse reactions.

http://www.sciencedaily.com/releases/2013/10/131023090722.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fpharmacology+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Pharmacology%29